Comorbid anxiety and depressive symptoms and the related factors among international medical students in China during COVID-19 pandemic: a cross-sectional study.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

COVID-19*/epidemiology ; COVID-19*/psychology ; Students, Medical*; Humans ; Depression/epidemiology ; Depression/diagnosis ; Cross-Sectional Studies ; Pandemics ; Anxiety/epidemiology ; Anxiety/diagnosis ; Anxiety Disorders/epidemiology ; Comorbidity ; China/epidemiology

Background: The two most prevalent mental health conditions are anxiety and depression and they often coexist (comorbidity) in an individual aggravating the person's psychological or medical conditions. College students suffered from anxiety and depressive symptoms during the COVID-19 pandemic, according to numerous studies. The lack of information on the comorbidity of anxiety and depression (CAD) among international medical students, however, makes it difficult to develop effective policies or strategies to support these students.
Objective: The present research seeks to investigate the incidence of CAD among international medical students in China and to identify the variables that may be useful in predicting CAD.
Method: A cross-sectional study was conducted at China Medical University in Shenyang, China, for international medical students during November 2020. A total of 519 international students provided information on their demographics, stress related to the COVID-19 pandemic, generalized anxiety disorder assessment (GAD-7), patient health questionnaire-9 (PHQ-9), simplified coping style questionnaire (SCSQ), perceived stress scale (PSS-10), the multidimensional scale of perceived social support (MSPSS), revised life orientation test (LOT-R), and resilience scale-14 (RS-14). To investigate the potential predictors of CAD, a chi-square test, a nonparametric test, and multinomial logistic regression analyses were carried out as appropriate.
Results: The incidence of anxiety, depression, and CAD in the current study was 5.8%, 8.9%, and 22.7%, respectively. The predictors for students having symptoms of anxiety were observed to be the negative coping style (β = 0.662, OR = 1.938, CI:1.07-3.694) and perceived stress (β = 0.167, OR = 1.181, CI:1.076-1.297); the predictors for students having symptoms of depression were observed to be the COVID-19 pandemic-related stress (β = 0.323,OR = 1.382,CI:1.211-1.577), negative coping style (β = 0.693,OR = 2.000, CI:1.21-3.568), and perceived stress (β = 0.135,OR = 1.145,CI:1.050-1.248); whereas the predictors for students with CAD were observed to be staying up late (Yes VS No) (β = 1.028,OR = 2.794,CI:1.227-6.364), current place of residence (Other continents VS China) (β = -1.413, OR = 0.243,CI:0.065-0.910), COVID-19 pandemic-related stress (β = 0.371,OR = 1.450,CI:1.284-1.636), negative coping style (β = 1.092,OR = 2.979,CI:1.706-5.203), and perceived stress (β = 0.339,OR = 1.403,CI:1.289-1.527).
Conclusion: Single anxiety and depressive symptoms were moderately prevalent among international medical students in China. However, CAD turned out to be the most prevalent mental health issue due to its relatively higher incidence. Negative coping style and perceived stress were the communal predictors of the three categories, whereas stress related to the COVID-19 pandemic was linked to both depression and CAD, and staying up late and in residential places were specific predictors for CAD. Study results suggest that COVID-19 pandemic-related stress was related to students' CAD and depressive symptoms, and specific intervention measures with stress reduction, proper coping strategy, and a good lifestyle might be useful in improving the international students' mental health status.
(© 2023. The Author(s).)

JNMA J Nepal Med Assoc. 2020 Jun 30;58(226):383-389. (PMID: 32788753)
PLoS One. 2015 Nov 20;10(11):e0142913. (PMID: 26587991)
BMC Med Educ. 2021 Jan 6;21(1):14. (PMID: 33407422)
Perspect Psychiatr Care. 2019 Apr;55(2):164-169. (PMID: 29797324)
Psychosom Med. 2004 May-Jun;66(3):411-21. (PMID: 15184705)
Behav Res Ther. 2021 Sep;144:103902. (PMID: 34174706)
Lancet. 2021 Aug 28;398(10302):747-758. (PMID: 34454673)
Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
JAMA Netw Open. 2020 Sep 1;3(9):e2019686. (PMID: 32876685)
JMIR Hum Factors. 2020 May 6;7(2):e17088. (PMID: 32374265)
Front Psychiatry. 2021 Nov 04;12:768132. (PMID: 34803775)
JAMA Netw Open. 2020 Oct 1;3(10):e2025591. (PMID: 33095252)
Pan Afr Med J. 2020 Sep 14;37:53. (PMID: 33209180)
Psychiatry J. 2020 May 28;2020:4956234. (PMID: 32550225)
BMC Med Educ. 2018 Feb 23;18(1):29. (PMID: 29471824)
Glob Adv Health Med. 2021 Mar 17;10:21649561211002461. (PMID: 34497735)
J Clin Psychol. 2002 Mar;58(3):307-21. (PMID: 11836712)
Int J Environ Res Public Health. 2019 Jul 31;16(15):. (PMID: 31370266)
J Pers Soc Psychol. 1994 Dec;67(6):1063-78. (PMID: 7815302)
Teach Learn Med. 2016;28(2):174-82. (PMID: 27064719)
Chronobiol Int. 2021 Apr;38(4):509-517. (PMID: 33397172)
Compr Psychiatry. 2020 Nov;103:152198. (PMID: 32980595)
Clin Psychol Rev. 2010 Mar;30(2):217-37. (PMID: 20015584)
Front Psychiatry. 2021 Nov 04;12:761964. (PMID: 34803770)
Med Educ. 2016 Apr;50(4):456-68. (PMID: 26995484)
Med Sci Sports Exerc. 2008 May;40(5):827-34. (PMID: 18408617)
Perspect Psychiatr Care. 2022 Oct;58(4):2394-2406. (PMID: 35332542)
J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417)
Psychiatr Danub. 2021 Summer;33(2):209-216. (PMID: 34185752)
J Affect Disord. 2017 Aug 15;218:93-104. (PMID: 28463712)
J Affect Disord. 2017 Oct 15;221:289-296. (PMID: 28668590)
Psychiatry Res. 2021 Jul;301:113863. (PMID: 33984824)
Int J Ment Health Addict. 2023;21(1):562-574. (PMID: 34393684)
Int J Clin Pract. 2021 Dec;75(12):e14839. (PMID: 34514706)
Psychiatry Res. 2018 Nov;269:316-320. (PMID: 30172189)
PLoS One. 2016 Apr 29;11(4):e0154729. (PMID: 27128438)
Stress Health. 2021 Dec;37(5):887-897. (PMID: 33739610)
J Pers Soc Psychol. 1986 Mar;50(3):571-9. (PMID: 3701593)
J Nurs Meas. 1993 Winter;1(2):165-78. (PMID: 7850498)
Adv Exp Med Biol. 2020;1191:561-576. (PMID: 32002946)
J Affect Disord. 2020 Oct 1;275:145-148. (PMID: 32658818)
Epidemiol Psychiatr Sci. 2021 Mar 26;30:e31. (PMID: 33766163)
J Affect Disord. 2021 Sep 1;292:89-94. (PMID: 34107425)
J Psychosom Res. 2015 Jun;78(6):519-28. (PMID: 25818837)
Int J Ment Health Syst. 2019 May 06;13:30. (PMID: 31080499)
J Subst Abuse Treat. 2021 Apr;123:108305. (PMID: 33612188)
Psychiatr Clin North Am. 2017 Dec;40(4):739-749. (PMID: 29080597)
Int J Environ Res Public Health. 2020 Jun 05;17(11):. (PMID: 32517044)
Brain Behav Immun. 2020 Oct;89:594-600. (PMID: 32738287)
Front Psychol. 2021 Mar 30;12:639955. (PMID: 33859594)
J Affect Disord. 2021 Apr 1;284:85-97. (PMID: 33588240)
BMJ Open. 2021 Aug 26;11(8):e054007. (PMID: 34446505)
Trends Psychiatry Psychother. 2021 Apr-Jun;43(2):141-150. (PMID: 34043898)
J Nerv Ment Dis. 2013 Sep;201(9):727-9. (PMID: 23995026)
J Clin Psychiatry. 1997;58 Suppl 8:3-5. (PMID: 9236728)
Addict Behav. 2013 Apr;38(4):1912-9. (PMID: 23380486)
J Am Coll Health. 2022 Oct;70(7):1947-1952. (PMID: 33253625)
Res Child Adolesc Psychopathol. 2021 Apr;49(4):503-517. (PMID: 33294962)
Adv Med Educ Pract. 2020 Nov 12;11:853-860. (PMID: 33209071)
J Pers Assess. 1990 Winter;55(3-4):610-7. (PMID: 2280326)
JAMA Netw Open. 2020 Jul 1;3(7):e2014053. (PMID: 32609353)
J Behav Cogn Ther. 2022 Mar;32(1):67-72. (PMID: 35018352)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
J Gen Psychol. 2022 Jul-Sep;149(3):279-298. (PMID: 33111653)

Keywords: Anxiety and depressive symptoms; COVID-19; Comorbidity; International medical students; Mental health; Perceived stress

Date Created: 20230315 Date Completed: 20230316 Latest Revision: 20230325

20240628

PMC10014140

10.1186/s12888-023-04638-7

36918819